Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 21 symbols : Jnj save search
Vaccinated Oregonians Qualify for $100,000 College Scholarships through "Take your shot" Campaign Partnership
Published: 2021-05-21 (Crawled : 22:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
| Email alert
Add to watchlist
partnership vaccine
Genmab Announces that Janssen has been Granted U.S. FDA Approval for RYBREVANT™ (amivantamab-vmjw) for Patients with Metastatic Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations
Published: 2021-05-21 (Crawled : 20:00) - globenewswire.com
GMAB | News | $28.85 -0.41% 260K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
| Email alert
Add to watchlist
fda lung cancer fda approval cancer ev growth approval
RYBREVANT™ (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Published: 2021-05-21 (Crawled : 19:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
| Email alert
Add to watchlist
treatment fda lung cancer fda approval cancer approval
Announcing BioNJ's BioPartnering Company & Pitch Presentation Award Honorees
Published: 2021-05-21 (Crawled : 17:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
presentation awards
FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
Published: 2021-05-21 (Crawled : 17:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
fda lung cancer therapy cancer approval fda approval
Study Indicates Sudden Hearing Loss Not Caused by COVID-19 Vaccines
Published: 2021-05-21 (Crawled : 17:00) - biospace.com/
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
covid vaccine hearing loss covid-19
Teen Scientists and Engineers Win $5 Million at Largest Global High School STEM Competition
Published: 2021-05-21 (Crawled : 16:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
REGN | News | $910.71 1.17% 150K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
Thinking about trading options or stock in AT&T, Ford, Johnson & Johnson, Nvidia, or Advanced Micro Devices?
Published: 2021-05-21 (Crawled : 15:00) - prnewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
ford ev device
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
Published: 2021-05-21 (Crawled : 13:15) - globenewswire.com
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
GMAB | News | $28.85 -0.41% 260K
|
Health Technology
|
| O: 1.34%
H: 0.71%
C: 0.13%
positive chmp als
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
Published: 2021-05-21 (Crawled : 09:00) - biospace.com/
TAK | News | $13.38 0.15% 1.3M
|
Health Technology
|
| O: 0.75%
H: 0.63%
C: -0.17%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.15%
H: 0.82%
C: -0.22%
covid vaccine approval covid-19
Gainers vs Losers
| 85% | 15% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.99 139.2% 64M
|
Finance
CZOO | $8.67 73.75% 23M
|
EDBL | News | $6.47 72.07% 1.9M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.